In epidemiology and clinical trials, Professor John McGrath aims to explore non-genetic risk factors – such as low vitamin D – that in time, could be modified to reduce the risk of mental disorders. He has forged cross-disciplinary collaborations linking risk factor epidemiology with developmental neurobiology, including in schizophrenia. John and his team have established the Cadence Clinical Trials Platform in South-East Queensland, concentrating on better clinical outcomes for people with psychosis; John also holds a prestigious Niels Bohr Professorship that sees him operate in Denmark, focussing on schizophrenia.
Research interests
The link between vitamin D status and brain outcomes, demographic and clinical correlates of psychotic-like experiences; psychosis, Cadence.
